Blog Posts

Pillr Health

Q: Tell us some interesting details about your company’s history.

Pillr Health was born from a passion for progress. Building on two decades of experience, we evolved this year with

Read More »

Expert Tip from Cervey

img
img

TIP: Prioritize referral consistency over volume.


When it comes to 340B referral capture, it’s tempting to focus

Read More »

News Alert

Federal Judge Grills Both Sides in Key Hearing on 340B Rebate Dispute

A hearing on five drug industry 340B rebate lawsuits took place April 29 in the U.S. District Court for the District of Columbia.
A federal judge today in Washington, D.C. scrutinized arguments from both manufacturers and the government in a closely watched hearing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Holds High-Stakes Hearings Today on Five Drug Industry 340B Rebate Lawsuits

U.S. District Judge Dabney Friedrich of the District of Columbia is presiding over five April 29 hearings over drugmaker 340B rebate lawsuits. She previously largely sided with Novartis and United Therapeutics in a separate case on drugmaker contract pharmacy restrictions.
A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Audits Find Two Drugmakers Overcharged for 340B Drugs, Driving Calls for More Drug Industry Oversight 

HRSA released the results of its first two drugmaker audits of 2025 this month.
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Stretching Scarce Federal Resources: How Conway Medical Center Is Redefining 340B’s Impact

SPONSORED CONTENT

The purpose of the 340B drug pricing program remains a contested question between 340B providers and some in the pharmaceutical industry. In addition, there are questions regarding 340B’s scope including the contract pharmacy program and the definition of patient.

Read More »

Former 340B Health, Evernorth Executives Join Walgreens 

Greg Doggett and Ben Olson, two long-time executives in the 340B world, have recently taken on key positions at retail pharmacy giant Walgreens.
Two influential players in the 340B world have recently taken on key positions at retail pharmacy giant Walgreens, one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California, Texas, Oklahoma Advance 340B Contract Pharmacy Access Bills with Key Amendments

California lawmakers recently advanced a 340B contract pharmacy access bill through committee but amended it to exclude 340B hospitals.
State legislators in California, Texas and Oklahoma have recently advanced 340B contract pharmacy access bills with amendments that in some [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Tightens 340B Contract Pharmacy Restrictions, Biogen Exempts Nebraska From Its Restrictions Policy

Japanese pharmaceutical giant Takeda recently announced changes to its 340B contract pharmacy restrictions.
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations

340B stakeholders offered mixed responses to the findings of U.S. Sen. Bill Cassidy's (R-La.) investigation into the 340B program.
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live